Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Malignant Lymphoma

Free Subscription Articles published in J Am Acad Dermatol Retrieve available abstracts of 45 articles: HTML format

Single Articles

March 2023
1. BAYKAL C, Atci T
   Clinical features and staging of mycosis fungoides of the eyelids: A retrospective cohort study.
   J Am Acad Dermatol. 2023;88:729-731.
   PubMed    
   
   
   
2. JOSHI TP, Black TA, Fernandez B, Friske S, et al
   Comorbidities associated with mycosis fungoides: A case-control study in the All of Us database.
   J Am Acad Dermatol. 2023;88:686-688.
   PubMed    
   
   
   January 2023
3. JACOB JS, Hunt RD
   Increasing incidence of pediatric mycosis fungoides from 2000 to 2017: A national population-based study of the Surveillance, Epidemiology, and End Results database and Texas Cancer Registry.
   J Am Acad Dermatol. 2023;88:185-187.
   PubMed    
   
   
   December 2022
4. COHEN JM, Damsky W, Girardi M
   Comment on "Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab".
   J Am Acad Dermatol. 2022;87:e241-e242.
   PubMed    
   
   
   
5. MCKENZIE S, Brown-Korsah JB, Syder NC, Omar D, et al
   Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color. Part II: Differences in clinical presentation and disparities in cutaneous disorders in skin of color.
   J Am Acad Dermatol. 2022;87:1261-1270.
   PubMed     Abstract available
   
   
   November 2022
6. CHUNG C, Espinosa ML, Walker CJ, Choi J, et al
   Acceleration of skin involvement may predict disease progression in early-stage mycosis fungoides: A retrospective cohort study.
   J Am Acad Dermatol. 2022;87:1140-1141.
   PubMed    
   
   
   October 2022
7. HOOPER MJ, Veon FL, Enriquez GL, Nguyen M, et al
   Retrospective analysis of sepsis in cutaneous T-cell lymphoma reveals significantly greater risk for Black patients.
   J Am Acad Dermatol. 2022 Oct 17. pii: S0190-9622(22)02900.
   PubMed     Abstract available
   
   
   
8. HEYMANN WR
   Differentiating hyperkeratotic palmoplantar dermatoses: Give your dermatopathologist a hand.
   J Am Acad Dermatol. 2022;87:752-753.
   PubMed    
   
   
   
9. BOZON A, Avinens O, Lacheretz-Szablewski V, Dereure O, et al
   Spatial and temporal homogeneity of T-cell receptor gamma chain rearrangements in mycosis fungoides: A next-generation sequencing analysis.
   J Am Acad Dermatol. 2022;87:908-910.
   PubMed    
   
   
   
10. BUECHLER CR, Sagher E, Tisack A, Jacobsen G, et al
    Contribution of socioeconomic risk factors within a diverse mycosis fungoides cohort from Detroit, Michigan.
    J Am Acad Dermatol. 2022;87:897-900.
    PubMed    
    
    
    
11. KIM SR, McNiff JM, Ko CJ
    Clustered intraepidermal lymphocytes and Langerhans cell microgranulomas are consistently observed in hyperkeratotic palmoplantar eczema compared with palmoplantar psoriasis and mycosis fungoides palmaris et plantaris.
    J Am Acad Dermatol. 2022;87:884-886.
    PubMed    
    
    
    September 2022
12. KIM SR, Ko CJ, Nelson CA, Ramachandran S, et al
    Random skin biopsies for diagnosis of intravascular large B cell lymphoma: retrospective analysis of 31 biopsies from a US dermatology inpatient consultative service with literature review.
    J Am Acad Dermatol. 2022 Sep 21. pii: S0190-9622(22)02740.
    PubMed    
    
    
    July 2022
13. HIMELES JR, Holton J, Vittorio C, Rook AH, et al
    Paying the Price of Cutaneous T-cell Lymphoma: An analysis of recent trends in skin directed and self-administered systemic treatment costs in the United States for Cutaneous T-cell Lymphoma.
    J Am Acad Dermatol. 2022 Jul 18. pii: S0190-9622(22)02251.
    PubMed    
    
    
    
14. QUERFELD C, Kim YH, Guitart J, Scarisbrick J, et al
    Use of chlormethine 0.04% gel for mycosis fungoides after treatment with topical chlormethine 0.02% gel: A phase 2 extension study.
    J Am Acad Dermatol. 2022;87:209-211.
    PubMed    
    
    
    June 2022
15. O'DONNELL M, Zaya R, Correia E, Krishnasamy S, et al
    Disease characteristics, prognosis, and response to therapy in patients with large-cell transformed mycosis fungoides: A single-center retrospective study.
    J Am Acad Dermatol. 2022;86:1285-1292.
    PubMed     Abstract available
    
    
    
16. SUH KS, Jang MS, Jung JH, Kwon DI, et al
    Clinical characteristics and long-term outcome of 223 patients with mycosis fungoides at a single tertiary center in Korea: A 29-year review.
    J Am Acad Dermatol. 2022;86:1275-1284.
    PubMed     Abstract available
    
    
    
17. CHOI J, Sutaria N, Roh YS, Bordeaux Z, et al
    Racial and ethnic disparities in inpatient health care utilization for mycosis fungoides: A cross-sectional analysis of the 2012-2017 National Inpatient Sample.
    J Am Acad Dermatol. 2022;86:1408-1410.
    PubMed    
    
    
    
18. JUNG JM, Yoo H, Lim DJ, Won CH, et al
    Clinicoprognostic implications of head and neck involvement by mycosis fungoides: A retrospective cohort study.
    J Am Acad Dermatol. 2022;86:1258-1265.
    PubMed     Abstract available
    
    
    May 2022
19. BESCH-STOKES JG, Costello CM, Severson KJ, Bhullar P, et al
    Primary cutaneous CD4(+) small/medium T-cell lymphoproliferative disorder: Diagnosis and management.
    J Am Acad Dermatol. 2022;86:1167-1169.
    PubMed    
    
    
    April 2022
20. CHERAGHLOU S, Ugwu N, Girardi M
    Treatment at high-volume facilities is associated with improved overall survival for patients with cutaneous B-cell lymphoma.
    J Am Acad Dermatol. 2022 Apr 24. pii: S0190-9622(22)00698.
    PubMed    
    
    
    
21. ERRICHETTI E, Geller S, Zalaudek I, Longo C, et al
    Dermatoscopy of nodular/plaque-type primary cutaneous T- and B-cell lymphomas: A retrospective comparative study with pseudolymphomas and tumoral/inflammatory mimickers by the International Dermoscopy Society.
    J Am Acad Dermatol. 2022;86:774-781.
    PubMed     Abstract available
    
    
    
22. NAWAR T, Elsayad K, Muller EC, Rolf D, et al
    Quality of life in patients with mycosis fungoides and Sezary syndrome undergoing low-dose total skin electron beam therapy with or without maintenance therapy.
    J Am Acad Dermatol. 2022;86:889-891.
    PubMed    
    
    
    
23. CARITI C, Quaglino P, Lupia T, Novelli M, et al
    Infections in Sezary syndrome: A retrospective cohort study of 113 patients.
    J Am Acad Dermatol. 2022;86:943-946.
    PubMed    
    
    
    March 2022
24. MAGHFOUR J, Gill F, Olson J, Guido N, et al
    Association of Airborne Toxins with Geographic Clustering of Cutaneous T Cell Lymphoma in Louisiana.
    J Am Acad Dermatol. 2022 Mar 7. pii: S0190-9622(22)00378.
    PubMed    
    
    
    January 2022
25. ABRAHAM J, Wei G, Desai SR, Seminario-Vidal L, et al
    A cross-sectional analysis of quality-of-life in skin of color patients with cutaneous t-cell lymphoma: an exploratory study.
    J Am Acad Dermatol. 2022 Jan 24. pii: S0190-9622(22)00100.
    PubMed    
    
    
    
26. BELLINATO F, Gisondi P, Girolomoni G
    Risk of lymphohematologic malignancies in patients with chronic plaque psoriasis: A systematic review with meta-analysis.
    J Am Acad Dermatol. 2022;86:86-96.
    PubMed     Abstract available
    
    
    
27. BEHBAHANI S, Yeh CJ, Fernandez JM, Chen ST, et al
    Gender differences in clinical presentation, treatment, and outcomes in mycosis fungoides.
    J Am Acad Dermatol. 2022;86:174-177.
    PubMed    
    
    
    December 2021
28. ROLF D, Elsayad K, Eich HT
    Ultra-hypofractionated low-dose total skin electron beam followed by maintenance therapy: Preliminary findings from a prospective open-label study.
    J Am Acad Dermatol. 2021;85:1601-1603.
    PubMed    
    
    
    November 2021
29. FERRIER A, Soong L, Alabdulsalam A, Kunimoto B, et al
    Diagnosis of gamma/delta mycosis fungoides requires longitudinal clinical observation.
    J Am Acad Dermatol. 2021;85:1352-1353.
    PubMed    
    
    
    
30. GOYAL N, O'Leary D, Rubin N, Bohjanen K, et al
    Localization patterns and survival of extranodal natural killer/T-cell lymphomas in the United States: A population-based study of 945 cases.
    J Am Acad Dermatol. 2021;85:1318-1321.
    PubMed    
    
    
    
31. OH Y, Stoll JR, Moskowitz A, Pulitzer M, et al
    Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sezary syndrome. Part II: Prognosis and management.
    J Am Acad Dermatol. 2021;85:1093-1106.
    PubMed     Abstract available
    
    
    
32. STOLL JR, Willner J, Oh Y, Pulitzer M, et al
    Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sezary syndrome. Part I: Clinical and histologic features and diagnosis.
    J Am Acad Dermatol. 2021;85:1073-1090.
    PubMed     Abstract available
    
    
    October 2021
33. LEWITT TM, Walker CJ, Espinosa ML, Chung C, et al
    Cutaneous T-Cell Lymphoma and Pregnancy: Great Uncertainty and an Appeal for Prospective Clinical Research.
    J Am Acad Dermatol. 2021 Oct 29. pii: S0190-9622(21)02725.
    PubMed    
    
    
    
34. SEVERSON KJ, Cumsky HJL, Brumfiel CM, Janeczek MC, et al
    Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study.
    J Am Acad Dermatol. 2021;85:969-971.
    PubMed    
    
    
    
35. KURAITIS D, McBurney E, Boh E
    Utility of clonal T-cell rearrangement study in the diagnosis of early mycosis fungoides.
    J Am Acad Dermatol. 2021;85:1040-1042.
    PubMed    
    
    
    September 2021
36. ROZENBAUM D, Tung J, Xue Y, Hoang MP, et al
    Skin biopsy in the diagnosis of intravascular lymphoma: A retrospective diagnostic accuracy study.
    J Am Acad Dermatol. 2021;85:665-670.
    PubMed     Abstract available
    
    
    
37. XUE R, Elbendary A, Liu H, Chen Y, et al
    Hydroa vacciniforme-like lymphoma: Clinicopathologic description, treatment, and outcome.
    J Am Acad Dermatol. 2021;85:752-755.
    PubMed    
    
    
    August 2021
38. SAMIE FH
    JAAD Game Changers *: Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides.
    J Am Acad Dermatol. 2021;85:537.
    PubMed    
    
    
    July 2021
39. GOYAL A, O'Leary D, Foreman RK, Duncan LM, et al
    Assessing the diagnosis of "primary cutaneous mantle cell lymphoma": A systematic review and population-based analysis.
    J Am Acad Dermatol. 2021 Jul 31. pii: S0190-9622(21)02201.
    PubMed    
    
    
    
40. TUNG JK, Rozenbaum D, Rrapi R, Chand S, et al
    Skin biopsy in the diagnosis of intravascular lymphoma: a retrospective diagnostic accuracy study.
    J Am Acad Dermatol. 2021 Jul 24. pii: S0190-9622(21)02168.
    PubMed    
    
    
    
41. ENZAN N, Kitadate A, Kono M
    Comment on skin biopsies for diagnosing intravascular lymphoma: a retrospective study of diagnostic accuracy.
    J Am Acad Dermatol. 2021 Jul 23. pii: S0190-9622(21)02167.
    PubMed    
    
    
    
42. NEWMAN NB, Patel CG, Ding GX, Zic JA, et al
    Prospective observational trial of low-dose skin electron beam therapy in mycosis fungoides using a rotational technique.
    J Am Acad Dermatol. 2021;85:121-127.
    PubMed     Abstract available
    
    
    March 2021
43. KARTAN S, Shalabi D, O'Donnell M, Alpdogan SO, et al
    Response to topical corticosteroid monotherapy in mycosis fungoides.
    J Am Acad Dermatol. 2021;84:615-623.
    PubMed     Abstract available
    
    
    December 2020
44. RAMACHANDRAN V, Park KE, Loya A, Duvic M, et al
    Second primary malignancies in blastic plasmacytoid dendritic cell neoplasm: A national database study.
    J Am Acad Dermatol. 2020;83:1786-1789.
    PubMed    
    
    
    November 2020
45. SCHACHTER O, Tabibian-Keissar H, Debby A, Segal O, et al
    Evaluation of the polymerase chain reaction-based T-cell receptor beta clonality test in the diagnosis of early mycosis fungoides.
    J Am Acad Dermatol. 2020;83:1400-1405.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: